Gold prices fall by 50 piasters in local market
The selling price for 21-karat gold is JD67.50 per gram, while the purchase price is JD65.50, according to the Jordanian Jewellers Syndicate (JJS).
The selling price of gold per gram for 24-karat and 18-karat reached JD77.50 and JD59.50 respectively.
The selling price of a gram of 14-karat gold reached JD45.70.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Ammon
39 minutes ago
- Ammon
Oil prices little changed as expectations for OPEC+ increase weigh
Ammon News - Oil futures were little changed on Wednesday as markets weighed expectations from more supply from major producers next month, a softer U.S. dollar and a mixed bag of economic and market indicators from the U.S., the world's largest oil consumer. Brent crude was up 2 cents at $67.13 a barrel at 0345 GMT, while U.S. West Texas Intermediate crude fell 1 cent to $65.44 a barrel. Brent has traded between a high of $69.05 a barrel and low of $66.34 since June 25, as concerns of supply disruptions in the Middle East producing region have ebbed following the ceasefire between Iran and Israel. Also weighing on prices, sources said American Petroleum Institute data late on Tuesday showed U.S. crude oil inventories rose by 680,000 barrels in the past week at a time when stockpiles typically draw amid the summer demand season. The market is already seeing the results of the previous OPEC+ increases with Saudi Arabia, the world's biggest oil exporter, lifting shipments in June by 450,000 bpd from May, according to data from Kpler, its highest in more than a year. Reuters
Ammon
18 hours ago
- Ammon
Bride slaps shocked guests with $500 fee
Ammon News - Ahead of getting hitched, one ballsy bride-to-be is arranging an 'absurd' marriage between her wedding guests' money and her personal bank account, hitting invitees with a steep attendance fee — as well as a GoFundMe gift request. 'Bride [is] renting a large estate for five days for a destination wedding,' ranted a Redditor of the unnamed nearly-wed. 'We were told, 'accommodations were taken care of,' and that we only needed to book flights/transportation.' 'Two months before the wedding she tells us that we each need to [send] $500 per person for accommodation costs,' the virtual complainer carped. Unfortunately, the grabby bride's surprises didn't end there. 'I checked the website,' added the sleuthy invitee. 'The venue fee includes access to the entire grounds, and the number of guests I've been told are coming [times] $500, [which] actually means she'll be making more than what the venue fee is.' On top of pocketing a tidy profit via wedding day well-wishers, the unabashed bride and groom are, too, urging guests to gift them with cash toward their post-nuptial bash. NYP
Ammon
20 hours ago
- Ammon
Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities
Ammon News - Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment will further expand Hikma's domestic capabilities to develop, produce and deliver a broad range of medicines. Hikma has operated in the US since 1991 and has spent more than $4 billion over the past 15 years to build, enhance and expand its US-based R&D and manufacturing capabilities and now has annual domestic capacity to produce more than 12 billion finished doses of essential medicines. Over this period, Hikma has provided patients with access to a wide range of generic medicines at a lower cost than branded products. The new phase of investment represents the Company's latest efforts to increase the volume of essential medicines it develops and produces across its R&D and manufacturing sites in Columbus and Cleveland, Ohio and in Cherry Hill and Dayton, New Jersey. This next phase of expansion will help to strengthen Hikma's portfolio of more than 800 medicines and increase the Company's US-based capacity to produce large volumes of high-quality and affordable medicines for American hospitals, providers and patients. 'We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients,' said Dr. Hafrun Fridriksdottir, President, Hikma Rx. 'Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines.'
